REFERENCES
- Arora A., Scholar EM. (2005) J Pharmacol Exp Ther., 315 971–9.
- de Kogel C.E., Schellens J.H. (2007) Oncologist., 12 1390–4.
- Druker B.J. (2004) Oncologist., 9, 357–60.
- Guilhot F. (2004) Oncologist., 9 271–81.
- Mauro M.J., Druker B.J. (2001) Oncologist., 6 233–8.
- Moen M.D., McKeage K., Plosker G.L., Siddiqui M.A. (2007) Drugs., 67 299–320.
- Shchemelinin I., Sefc L., Necas E. (2006) Folia Biol. (Praha), 52 137–48.
- Siddiqui M.A., Scott L.J. (2007) Drugs., 67 805–20.
- Suzuki R., Rao P., Sasaguri S. (2007) Curr Cancer Drug Targets., 7 273–84.
- Yaish P., Gazit A., Gilon C. and Levitzki A. (1988) Science, 242 933–935.